Join us for the UKKA AGM + updates on CKD management
We're excited to combine our AGM with an engaging educational webinar: Updates on CKD management - a new role for GLP-1 agonists.
Wednesday, 13 November 2024
16:30 – 17:45
This is a members-only event
New treatments for people with CKD: a focus on GLP-1 agonists
Jim Burton, UKKA Clinical Vice President, Consultant Nephrologist
-
Understand the emerging data on the use of GLP-1 agonists in people with kidney disease
-
Appreciate the use across cardio-renal and metabolic indications
-
Strategies to ensure equity of access to treatment
UKKA Annual General Meeting
ORDINARY BUSINESS
-
To approve the minutes of the last AGM
-
To approve the annual report for the year ended December 2023
-
To confirm appointments of:
-
Linda Tarm, Trustee - MPT Honorary Membership and Policy Secretary
-
Laura Meaden, Trustee - Non-Member
-
Mark Froud, Trustee - Non-Member
-
Stephen Marks, Trustee - Vice President (Paediatrics)
-
K-Fit: A Revolutionary Weight Loss Programme for Patients Living with End Stage Kidney Disease and Obesity
Sarah Afuwape, Psychologist
Ammar Al Midani, Consultant Transplant Surgeon
Natasha Aruk, Physiotherapist
Denise Cunningham, Pharmacist
Jacqueline Gandy, Dietitian
Transforming your local system for CKD care: Darzi and beyond
Paul Cockwell, UKKA Past-President, Consultant Nephrologist
-
Understand the current landscape for circulatory and CKD population health management
-
Outline conclusions from the Darzi report
-
Identify key principles for kidney leadership in local systems
NOTICE OF GENERAL MEETING
NOTICE is hereby given of the Annual General Meeting (Meeting) of The UK Kidney Association. Following a merger of the British Renal Society and the Renal Association, The UK Kidney Association (UKKA) is a trading name of The Renal Association, a charitable company limited by guarantee registered in England and Wales (company number 02229663, charity number 800733), with registered office at Brandon House Building 20a1 Brandon House Building 20a1 Southmead Road, Bristol, England, BS34 7RR.
The Meeting will be held via Zoom webinar, on Wednesday 13 November at 16:30, to transact the following business: Members will be asked to consider and if thought fit, pass the following resolutions: Resolutions 1 – 3 constitute the ordinary business of the Meeting.
As a member of the Company, you are entitled to appoint a proxy to exercise all or any of your rights to attend, speak and vote at a general meeting of the Company. You can appoint a proxy by emailing ukka@ukkidney.org on or before Wednesday 6 November 2024.
